Cognition Therapeutics, Inc. Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to helping millions of families seeking effective treatments for devastating neurodegenerative diseases through the development of novel, accessible therapies. The company is advancing its lead candidate, zervimesine (CT1812), for the development of DLB psychosis.